tiprankstipranks
eFFECTOR Therapeutics (EFTR)
OTHER OTC:EFTR
US Market
EFTR
eFFECTOR Therapeutics
RESEARCH TOOLSreports
Want to see EFTR full AI Analyst Report?

eFFECTOR Therapeutics (EFTR) Income Statement

264 Followers

eFFECTOR Therapeutics Income Statement

Last quarter (Q1 2024), eFFECTOR Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, eFFECTOR Therapeutics's net income was $-8.83M. See eFFECTOR Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 3.55M$ 1.43M$ 42.00M$ 0.00
Gross Profit
$ -111.00K$ 3.50M$ 1.41M$ 42.00M$ -307.00K
Operating Expenses
$ 33.84M$ 35.90M$ 33.30M$ 26.18M$ 28.30M
Depreciation and Amortization
$ 111.00K$ 53.00K$ 24.00K$ 160.00K$ 307.00K
EBITDA
$ -32.78M$ -20.36M$ 17.59M$ 16.05M$ -28.05M
Operating Income
$ -33.84M$ -32.40M$ -33.33M$ 15.82M$ -28.61M
Other Income/Expenses
$ -1.97M$ 9.74M$ 0.00$ -1.26M$ -1.13M
Pretax Income
$ -35.81M$ -22.66M$ 15.80M$ 14.56M$ -29.74M
Net Income
$ -35.81M$ -12.93M$ 15.80M$ 14.21M$ -29.74M
Per Share Metrics
Basic EPS
$ -16.37$ -7.85$ 9.78$ 0.28$ -539.08
Diluted EPS
$ -16.37$ -7.85$ 9.78$ 0.10$ -539.08
Weighted Average Shares Outstanding
 2.19M 1.65M 1.62M 598.56K 55.17K
Weighted Average Shares Outstanding (Diluted)
 2.19M 1.65M 1.62M 598.56K 55.17K
Currency in USD

eFFECTOR Therapeutics Earnings and Revenue History